Linical Co (TSE:2183) Total Payout Ratio: -0.12 (As of Aug. 19, 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Linical Co Ltd TSE:2183

41 GF Score

Price 円204.00

GF Value 円331.00

Valuation Possible Value Trap

5 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Linical Co Total Payout Ratio?

Linical Co TSE:2183 -2.86% 41 Total Payout Ratio is -0.12 as of Aug. 19, 2026. GuruFocus rates TSE:2183 with a GF Score™ of 41/100 and a GF Value™ of 円331.00 (Possible Value Trap). The stock has 5 warning signs investors should review.

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Linical Co's current Total Payout Ratio is -0.12.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Linical Co Total Payout Ratio Related Terms

Linical Co Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for Linical Co's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co Total Payout Ratio Chart

Linical Co Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Total Payout Ratio

Get a 7-Day Free Trial

0.31

0.23

0.48

-0.66

-0.12

Linical Co Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25	Mar26
Total Payout Ratio	Get a 7-Day Free Trial															0.00	-1.41	0.00	-0.67	0.00

TSE:2183 vs VRTX, REGN, RVMD: Total Payout Ratio Comparison

For the Biotechnology subindustry, Linical Co's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Linical Co Total Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Linical Co's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Linical Co's Total Payout Ratio falls into.

Save Embed

41GF Score

Linical Co Ltd TSE:2183

Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Linical Co Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Linical Co's Total Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	-360.945)	/	-3013.53
	=	-0.12

Linical Co's Total Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	-0.079)	/	-2470.507
	=	-0.00

Frequently Asked Questions Learn more about Total Payout Ratio →

What does a Total Payout Ratio of -0.12 mean?

Linical Co (TSE:2183) has a Total Payout Ratio of -0.12 as of Aug. 19, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Linical Co and its competitors.

Is Linical Co's Total Payout Ratio too high?

Linical Co's current Total Payout Ratio is -0.12. Overall, Linical Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Linical Co's Total Payout Ratio compare to VRTX and REGN?

Linical Co's Total Payout Ratio of -0.12 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Payout Ratio for a Biotechnology company?

A good Total Payout Ratio depends on the Biotechnology industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Payout Ratio mean?

A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Linical Co and its competitors. Linical Co's current Total Payout Ratio is -0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Linical Co stock overvalued right now?

Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円331.00, compared to a current price of 円204.00 — trading 38.4% below its estimated fair value. The current Total Payout Ratio is -0.12. Linical Co's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Payout Ratio calculated?

Total Payout Ratio is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Total Payout Ratio is -0.12 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円204.00 is trading 38.4% below its estimated GF Value™ of 円331.00. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

Total Payout Ratio: -0.12
GF Value™: 円331.00 vs. price of 円204.00 (38.4% below fair value)
GF Score™: 41/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →